T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma

T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma

Despite impressive progress, a significant portion of patients still experience primary or secondary resistance to chimeric antigen receptor (CAR) T-cell immunotherapy for relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL). The mechanism of primary resistance involves T-cell extrinsic and...

Full description

Bibliographic Details
Main Authors:	Jiachen Wang, Kefeng Shen, Wei Mu, Weigang Li, Meilan Zhang, Wei Zhang, Zhe Li, Tong Ge, Zhoujie Zhu, Shangkun Zhang, Caixia Chen, Shugang Xing, Li Zhu, Liting Chen, Na Wang, Liang Huang, Dengju Li, Min Xiao, Jianfeng Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Immunology
Subjects:	CAR-T cell immunotherapy immune resistance primary immunodeficiencies T cell dysfunction germline alterations LDH – lactate dehydrogenase
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.873789/full

Similar Items

Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report
by: Kefeng Shen, et al.
Published: (2022-10-01)

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations
by: Li Yang, et al.
Published: (2019-10-01)

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy
by: Wei Mu, et al.
Published: (2022-02-01)

Clinical Utility of Droplet Digital PCR to Monitor BCR-ABL1 Transcripts of Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Post-chimeric Antigen Receptor19/22 T-Cell Cocktail Therapy
by: Yuqi Guan, et al.
Published: (2021-04-01)

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV‐associated lymphoproliferative disease
by: Kefeng Shen, et al.
Published: (2023-01-01)

Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma
by: Wei Mu, et al.
Published: (2023-12-01)

Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs)
by: Xinyue Deng, et al.
Published: (2024-01-01)

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
by: Peiling Zhang, et al.
Published: (2022-10-01)

Polymerase acidic subunit of H9N2 polymerase complex induces cell apoptosis by binding to PDCD 7 in A549 cells
by: Shaohua Wang, et al.
Published: (2021-04-01)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
by: Nan Yan, et al.
Published: (2021-07-01)

Progress of CD8+CD25+regulatory T cells in diseases
by: WEN Li-na, CHEN Li, DUAN Rui, LI Fang
Published: (2022-12-01)

Functional diversification and dynamics of CAR-T cells in patients with B-ALL
by: Zongcheng Li, et al.
Published: (2023-10-01)

Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
by: Zhang Y, et al.
Published: (2023-01-01)

Inflammatory abrasion of hematopoietic stem cells: a candidate clue for the post-CAR-T hematotoxicity?
by: Ting Sun, et al.
Published: (2023-05-01)

CD4+CD25+CD127 regulatory cells play multiple roles in maintaining HIV-1 p24 production in patients on long-term treatment: HIV-1 p24-producing cells and suppression of anti-HIV immunity
by: Yan-Mei Jiao, et al.
Published: (2015-08-01)

MKL-1 regulates the stem cell marker. CD44 in breast cancer cells
by: Dai Zhou-Tong, et al.
Published: (2019-01-01)

CD14 facilitates perinatal human cytomegalovirus infection in biliary epithelial cells via CD55
by: Liang Su, et al.
Published: (2024-05-01)

CD4+CD25+ Regulatory T Cells Decreased CD8+IL-4+Cells in a Mouse Model of Allergic Asthma
by: Ping Li, et al.
Published: (2019-08-01)

Higher CD4+CD40+ T cells (Th40 cells) associate with systemic lupus erythematosus activity
by: Lihua Zhu, et al.
Published: (2023-07-01)

Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells
by: Yongyan Wu, et al.
Published: (2018-06-01)

Combining CD4 count, CD8 count and CD4/CD8 ratio to predict risk of mortality among HIV-positive adults after therapy: a group-based multi-trajectory analysis
by: Jing Ma, et al.
Published: (2023-12-01)

Advances in Universal CAR-T Cell Therapy
by: Haolong Lin, et al.
Published: (2021-10-01)

Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells
by: Chenfeng Han, et al.
Published: (2024-02-01)

Anti-CD34-Grafted Magnetic Nanoparticles Promote Endothelial Progenitor Cell Adhesion on an Iron Stent for Rapid Endothelialization
by: Jialong Chen, et al.
Published: (2019-11-01)

A glance through the effects of CD4+ T cells, CD8+ T cells, and cytokines on Alzheimer's disease
by: Atefeh Afsar, et al.
Published: (2023-01-01)

The effects of 308-nm excimer laser on the infiltration of CD4+, CD8+ T-cells, and regulatory T cells in the lesional skin of patients at active and stable stages of nonsegmental vitiligo
by: Baoxiang Zhang, et al.
Published: (2021-08-01)

Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion
by: Xuemei Gu, et al.
Published: (2023-12-01)

Band diagrams and performance of CdTe solar cells with a Sb2Te3 back contact buffer layer
by: Songbai Hu, et al.
Published: (2011-12-01)

Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
by: Qingqing Wu, et al.
Published: (2014-01-01)

Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2021-07-01)

Phenotypical changes and clinical significance of CD4+/CD8+ T cells in SLE
by: Jiawei Li, et al.
Published: (2022-07-01)

P1216: CD30 PROTECTS EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA CELLS AGAINST MITOCHONDRIAL DYSFUNCTION THROUGH INCREASING BNIP3 EXPRESSION
by: Wei-Ting Wang, et al.
Published: (2023-08-01)

Identification of clinically relevant subsets CD39+PD-1+CD8+ T cells and CD39+ regulatory T cells in intrahepatic cholangiocarcinoma using single-cell CyTOF
by: Qi-Wei Zhang, et al.
Published: (2024-06-01)

Pathological proliferation: a potential mechanism for poor CD4+ T cell recovery in people living with HIV
by: Yang Zhang, et al.
Published: (2024-03-01)

CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report
by: Yao Sun, et al.
Published: (2021-10-01)

Study of Temperature Effects on the Design of Active Region for 808 nm High-Power Semiconductor Laser
by: Shunhua Wu, et al.
Published: (2023-01-01)

Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
by: Yi Li, et al.
Published: (2016-01-01)

Influences of Low Intensity on Diode Parameters of CdTe Solar Cells
by: Xiaobo Xu, et al.
Published: (2020-05-01)

Prediction of CD3 T cells and CD8 T cells expression levels in non-small cell lung cancer based on radiomic features of CT images
by: Lujiao Chen, et al.
Published: (2023-02-01)

CD4(+)CD62L(+) central memory T cells can be converted to Foxp3(+) T cells.
by: Xiaolong Zhang, et al.
Published: (2013-01-01)